Speaker illustration

Doctor Patrick Blin

University of Bordeaux, Bordeaux (France)

Patrick Blin, MD, PhD is a physician specialized in Public Health, Pharmacoepidemiology and Biostatistics. He has been working for more than 30 years as scientific director and consultant in epidemiology and pharmacoepidemiology, conducting either field or database-based studies with more than 100 papers in peer-reviewed journals, including several in the field of cardiology. He is the scientific director of the Bordeaux Pharmaco Epi (BPE) Platform of the Bordeaux University since 2012.

Should dual antiplatelet therapy be maintained beyond one year after a myocardial infarction? A cohort study within the French SNDS nationwide claims database

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Acute coronary syndromes - Imaging and beyond

Thumbnail

Cardiovascular or renal disease (CVRD) complication and mortality incidence for type 2 diabetics with a single or without CVRD comorbidity: a 5-year SNDS nationwide claims database cohort study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Risks for acute coronary syndromes

Thumbnail

This platform is supported by

logo Novo Nordisk